The impact of age,gender and severity of overactive bladder wet on quality of life,productivity,treatment patterns and satisfaction

Haylen BT de Ridder D Freeman RM et al An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4–20.

Stewart WF Rooyen JB Cundiff GW et al Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–336.

Sand P Steers W Dmochowski R et al Patient-reported most bothersome symptoms in OAB: Post hoc analysis of data from a large, open-label trial of solifenacin. Int Urogynecol J 2009; 20: 667–675.

Vaughan CP Johnson TM II Ala-Lipasti MA et al The prevalence of clinically meaningful overactive bladder: Bother and quality of life results from the population-based FINNO Study. Eur Urol 2011; 59: 629–636.

Coyne KS Zhou Z Thompson C et al The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003; 92: 731–735.

van der Vaart CH de Leeuw JR Roovers JP et al The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 2002; 90: 544–549.

Lee KS Choo MS Seo JT et al Impact of overactive bladder on quality of life and resource use: Results from Korean Burden of Incontinence Study (KOBIS). Health Qual Life Outcomes 2015; 13: 89–96.

Irwin DE Milsom I Kopp Z et al Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2006; 97: 96–100.

Tang DH Colayco DC Khalaf KM et al Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int 2014; 113: 484–491.

Currie CJ McKewan P Poole CD et al The impact of the overactive bladder on health-related utility and quality of life. BJU Int 2006; 97: 1267–1272.

Milsom I Kaplan SA Coyne KS et al Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: Results from EpiLUTS. Urology 2012; 80: 90–96.

Coyne KS Wein A Nicholson S et al Economic burden of urgency urinary incontinence in the United States: A systematic review. J Managed Care Pharm 2014; 20: 130–140.

Brodszky V Gulacsi L Majoros A et al Cost of illness of overactive bladder syndrome in Hungary. In: ISPOR 15th Annual European Congress, Berlin, Germany, 3 November–7 November 2012, abstract no. PUK7, pp.A277–A575. New Jersey: ISPOR.

Tang DH Colayco D Piercy J et al Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol 2014; 14: 74.

Coyne KS Sexton CC Thompson CL et al Impact of overactive bladder on work productivity. Urology 2012; 80: 97–103.

Basra R Kelleher CJ. Disease burden of overactive bladder: Quality-of-life data assessed using ICI-recommended instruments. Pharmacoeconomics 2007; 25: 129–142.

Kelleher CJ Cardozo LD Khullar V et al A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997; 104: 1374–1379.

Reese P Pleil A Okano G et al Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder. Qual Life Res 2003; 12: 427–442.

Kelleher CJ Pleil AM Reese PR et al How much is enough and who says so? Br J Obstet Gynaecol 2004; 111: 605–612.

Schurch B Denys P Kozma CM et al Reliability and validity of the Incontinence Quality of Life Questionnaire in patients with neurogenic urinary incontinence. Am Arch Rehabil Ther 2007; 88: 646–652.

The EuroQol Group. EQ-5D-5L User guide. Basic information on how to use the EQ-5D-5L instrument. Version 2.1. April 2015. Rotterdam, The Netherlands: EuroQol Research Foundation. Available at: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdf (accessed 5 June 2017).

Reilly MC Zbrozek AS Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353–365.

Janssen MF Pickard AS Golicki D et al Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Qual Life Res 2013; 22: 1717–1727.

Hess LM Method MW Stehman FB et al Patient recall of health care events and time to diagnose a suspected ovarian cancer. Clinical Ovarian & Other Gynecologic Cancer 2012; 5: 17–23.

Richards SH Coast J Peters TJ. Patient-reported use of health service resources compared with information from health providers. Health Soc Care Community 2003; 11: 510–518.

Chiaffarino F Parazzini F Lavezzari M et al Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003; 43: 535–538.

Oh SJ Ku JH. Impact of self-perceived bothersomeness on health-related quality of life in women with overactive bladder symptoms. Urol Int 2007; 7: 63–69.

Desroziers K Aballéa S Maman K et al Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder. Health Qual Life Outcomes 2013; 11: 200.